NCT07713862Not yet recruiting
Midlife Empowerment and Longevity Through Optimizing Wellness
Enhancing Healthy Longevity in At-Risk Midlife Women With Abdominal Obesity: A Digital Phenotyping Commitment Device on Improving Visceral Body Fat Mass, Menopausal Symptoms and Cardiometabolic Risk Factors
Source: ClinicalTrials.gov · Last updated 23 Jul 2026
Brief summary (registry, in English)
The goal of this observational longitudinal study is to understand how lifestyle behaviours, menopausal symptoms, and digital health data change over time in women experiencing perimenopause or menopause, and to evaluate whether a personalised digital health programme can support healthier lifestyle behaviours and improve cardiometabolic health. The main questions it aims to answer are: 1. Can personalised lifestyle recommendations informed by wearable devices, dietary logging, and self-reported symptoms improve adherence to healthy diet, physical activity, and sleep behaviours? 2. How are menopausal symptoms associated with changes in cardiometabolic health, body composition, physical function, and quality of life over time? Participants will: 1. Attend study visits at the National University of Singapore for health assessments, including measurements of body composition, physical function, and cardiometabolic health. 2. Wear a smartwatch or wearable device to monitor physiological and activity data throughout the study. 3. Use a mobile application to record dietary intake, menopausal symptoms, and other health-related information. 4. Receive personalised lifestyle recommendations based on their health data and engage in regular follow-up assessments over the study period.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 15 Jul 2026
- Start date
- Jan 2027
- Primary completion date
- Jan 2029
- Lead sponsor
- National University Health System, Singapore
- Diseases
- Obesity
- NCT number
- NCT07713862
What you commit to
- Study type: Interventional
- Planned participants: 200
- From Jan 2027 to the primary completion date, Jan 2029
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Are currently receiving hormone replacement therapy (HRT);
- Are currently using oral contraceptives;
Other illness
- Have been diagnosed with severe psychiatric illness requiring inpatient care;
- Have significant cognitive impairment or inability to engage with digital tools;
- Have uncontrolled chronic medical conditions that may interfere with study participation;
Other
- Are concurrently enrolled in another behavioural or psychotherapy trial;
- Unable to comprehend written and spoken English.
Who the study is looking for
- Women aged 21-65 years old;
- Report at least mild climacteric symptoms as indicated by an MRS score ≥5;
- Waist circumference ≥80 cm, indicating abdominal adiposity;
- Own and use a smartphone compatible with the CGM and Oura Ring.
Age in the registry: 21 years to 65 years · Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.